
THE SHROOMVERSE JOURNAL ✳ 16 MIN READ
Is DMT legal in Canada? What the federal law says in 2026
Topic: Law and policy in Canada
Published Updated
Listen: the 3-minute version
AI-narrated summary of this article
Short answer, checked 20 October 2026
No. N,N-dimethyltryptamine (DMT) is item 7 of Schedule III of the federal Controlled Drugs and Substances Act, so possessing, trafficking in, importing, exporting or producing it is an offence unless the regulations or a ministerial exemption allow it. The new Controlled Substances Regulations, in force since 1 October 2026, list DMT as a restricted drug; they do not make it legal. Narrow authorized routes exist: clinical trials, the Special Access Program and section 56 exemptions, which Health Canada has considered for religious ayahuasca use. 5-MeO-DMT is not named in the Act’s schedules. British Columbia’s decriminalization pilot never covered DMT and expired on 31 January 2026.
THE SHORT VERSION · SWIPE







On this page 10 sections
The federal answer is short, but the details matter. This guide sets out what the statute and the new regulations say, which routes Health Canada describes for authorized use, and where the official record runs out. Every statement was checked against an official page on 20 October 2026. For what DMT is and how it compares with psilocybin and LSD, see our explainer on psilocybin, LSD and DMT.
General information, not legal advice
This page explains public legal documents. It cannot tell you how the law applies to your situation; for that, speak to a lawyer. It does not help anyone obtain a substance or avoid the law. In a medical emergency after taking any substance, call 911. For a possible poisoning, the Ontario Poison Centre lists 1-800-268-9017 and says it is available by phone 24 hours a day, every day of the year. For a suicide crisis or emotional distress, call or text 9-8-8. Our safety page lists more help.
Is DMT legal in Canada?
No. Schedule III of the Controlled Drugs and Substances Act (CDSA) lists, at item 7, “N,N-Dimethyltryptamine (DMT) (3-[(2-dimethylamino) ethyl]indole) and any salt thereof” (Justice Laws). The consolidation we read is current to 30 September 2026 and was last amended on 18 July 2026. Once a substance is in a schedule, the Act’s offences for that schedule apply to it unless the regulations or an exemption from the Minister of Health authorize the activity. Evidence: established.
The same schedule also lists two other chemicals that come up in discussions of ayahuasca: harmaline at item 9 and harmalol at item 10 (Justice Laws). We mention them only because they are on the face of the schedule; this page does not describe any plant or preparation. Evidence: established.
Which offences apply to DMT, and what are the maximum penalties?
Because DMT is a Schedule III substance, it carries the Schedule III penalties (Justice Laws). The table sets out the main offences in plain words and the maximums the Act states. A maximum is the ceiling Parliament set, not a prediction of what a court would impose in any case. Our guide to penalties for psilocybin in Canada explains sentencing and diversion for the same schedule in more depth.
| Offence | Section | What the section says, in plain words | Maximum penalty |
|---|---|---|---|
| Possession | 4(1), 4(6) | No person shall possess a Schedule I, II or III substance “except as authorized under the regulations”. | Indictable: up to 3 years in prison. Summary: first offence, a fine up to $1,000 or up to 6 months, or both; later offence, a fine up to $2,000 or up to 1 year, or both. |
| Trafficking, and possession for the purpose of trafficking | 5(1), 5(2), 5(3) | No trafficking in a Schedule III substance, or in anything held out to be one, and no possession for that purpose. | Indictable: up to 10 years. Summary: up to 18 months. |
| Import and export, and possession to export | 6(1), 6(2), 6(3) | Except as authorized under the regulations, no importing into or exporting from Canada, and no possession for the purpose of exporting. | Indictable: up to 10 years. Summary: up to 18 months. |
| Production | 7(1), 7(2) | Except as authorized under the regulations, no person shall produce a Schedule III substance. | Indictable: up to 10 years. Summary: up to 18 months. |
| Things intended for production or trafficking | 7.1(1), 7.1(2) | No possessing, producing, selling, importing or transporting anything intending it to be used to produce a controlled substance or to traffic in one. | Indictable: up to 10 years. Summary: up to 18 months. |
The definitions in section 2(1) are wide. “Traffic” includes to sell, administer, give, transfer, transport, send or deliver a substance, or to offer to do so, otherwise than under the authority of the regulations. Giving counts even if no money changes hands. “Produce” means obtaining a substance by any method or process, including cultivating, propagating or harvesting “any living thing from which the substance may be extracted or otherwise obtained” (Justice Laws). Evidence: established.
Part I.1 of the Act asks police and prosecutors to consider a warning, a referral or alternative measures before laying or prosecuting a simple possession charge, but it does not remove the offence. Section 4.1 protects a person who calls for emergency help in a medical emergency caused by a psychoactive substance, and people at the scene when help arrives, from being charged or convicted of possession under section 4(1) on evidence found because of that call (Justice Laws). It covers that one offence only. Evidence: established.
Are DMT-containing plants and ayahuasca a legal grey area?
The text of the Act does not create one. Section 2(2) says that, for the purposes of the Act, a reference to a controlled substance includes “any substance that contains a controlled substance” and “all synthetic and natural forms of the substance” (Justice Laws). The DMT entry in Schedule III contains no exception for plants. For what ayahuasca is, see what is ayahuasca. Evidence: established.
Compare the mescaline entry, item 17 of the same schedule, which reads “Mescaline … and any salt thereof, but not peyote (lophophora)” (Justice Laws). That is what an express plant exception looks like in the Act, and the DMT entry has no equivalent wording. We did not review case law on particular plant materials, so this page does not say how a court has treated or would treat any specific situation. A lawyer can advise on that.
For ayahuasca specifically, the official record we found points the same way. The Information Commissioner’s 2024 report on a complaint against Health Canada describes a request for records about “an application for religious exemption to serve ayahuasca under the provisions of section 56” of the Act. Health Canada told the Commissioner the application was still under review and “had the potential to set a precedent for future applications” (Information Commissioner of Canada). In other words, the department treated serving ayahuasca as an activity that needs a section 56 exemption. Evidence: established for what the report says.
What is a section 56 exemption, and have ayahuasca churches received one?
Section 56(1) lets the Minister, on any terms and conditions the Minister considers necessary, exempt any person, class of persons or controlled substance from all or part of the Act or its regulations if, in the Minister’s opinion, the exemption “is necessary for a medical or scientific purpose or is otherwise in the public interest” (Justice Laws). Religious use is not named in the section; a religious request would fall under the general wording.
Health Canada’s exemptions page says an exemption is a formal document issued to a person or group that authorizes specific activities which would otherwise be illegal. It usually sets how long it is valid and attaches terms and conditions, Health Canada reviews each request case by case, and it can revoke an exemption at any time if the holder does not comply (Health Canada).
Have Canadian ayahuasca churches received exemptions? News and community sources report that some churches did, starting in 2017; our ayahuasca vs DMT guide sets out that reported history and its limits. We could not confirm it from an official page. Health Canada does not publish a list of religious exemptions that we could find, and the Information Commissioner’s report confirms only that at least one religious application was pending when the complaint was investigated (Information Commissioner of Canada). Evidence: preliminary for the reported exemptions.
What is clear from the Act is that an exemption applies on the terms and conditions the Minister sets, and that section 56(1) can name a person, a class of persons or a controlled substance. A group’s exemption therefore usually covers only the people named in it, on its own terms, and does not make DMT or ayahuasca legal for anyone outside it (Justice Laws). For how individual exemptions have worked for psilocybin, see our section 56 explainer. Evidence: established.
Are there legal routes for DMT research or treatment?
Yes, narrow ones, each with a regulator, a practitioner or an ethics board in the loop. None is open to the public.
Clinical trials
In Health Canada’s Clinical Trials Database, one drug product names dimethyltryptamine, with ATAI Therapeutics listed as the manufacturer. Its protocol, VLS-01-203, is described as a phase 2, multicenter, double-blind, randomized, placebo-controlled trial of an investigational DMT product, VLS-01, in adults with treatment-resistant depression. Health Canada issued its no-objection letter on 7 November 2024, the start date is given as 4 June 2025, and the status was “ongoing” when we checked (Health Canada Clinical Trials Database). The record does not give results, and an authorized trial is not evidence that a drug works or is safe. Evidence: established for the record.
On ClinicalTrials.gov, the same VLS-01 trial (NCT06524830) lists two Canadian sites, in Surrey, British Columbia and Kingston, Ontario, and its status was “recruiting” on 20 October 2026 (ClinicalTrials.gov, NCT06524830). A keyword search there for “dimethyltryptamine” on the same day returned 61 studies, none listing a Canadian site, because the VLS-01 record names its drug by code rather than by that word (ClinicalTrials.gov). Registries and keyword searches miss things, so neither number is a full count of DMT research. For what the trials have found, see DMT therapy research.
The Special Access Program
Health Canada says amendments to the Food and Drug Regulations made it possible for health care practitioners to request restricted drugs through the Special Access Program (SAP) as of January 2022. Requests are judged case by case on the evidence for the use and the patient’s clinical history, and an authorization is not an endorsement of the drug (Health Canada notice). Patients cannot apply themselves. The notice names psilocybin and MDMA; it does not mention DMT, and we found no official figure on SAP requests for DMT. Our guide to the Special Access Program explains the process. Evidence: established for what the notice says.
What changed on 1 October 2026?
The Controlled Substances Regulations (SOR/2025-242) came into force on 1 October 2026 under their section 239. They consolidate older instruments, including Part J of the Food and Drug Regulations, which governed restricted drugs. DMT is item 4 of Part 1 of their Schedule 4, the list of restricted drugs, beside harmaline and harmalol at items 6 and 7 (Canada Gazette). Evidence: established.
Section 6(1) of the regulations lists who may possess a Part 1 restricted drug obtained in accordance with them: licensed dealers, certain pharmacists and pharmacy technicians, a practitioner named in a letter of authorization, the Minister, certain officials and researchers in connection with their employment, a person holding it for destruction, and, in paragraph (g), “an individual who has obtained the restricted drug for their own use from a practitioner named in a letter of authorization”. A letter of authorization is one issued under section C.08.010 of the Food and Drug Regulations, the SAP provision (Canada Gazette).
These are regulations under the Act, so they do not change Schedule III or the offences in the table above, and they do not create any route for the public (Justice Laws; Canada Gazette). This is general information, not legal advice. Evidence: established.
What about 5-MeO-DMT?
5-MeO-DMT is a different molecule from DMT; our 5-MeO-DMT vs DMT guide explains how. We searched the Act’s schedules and Schedule 4 of the new regulations and found no entry naming it; the tryptamines named in Schedule III are DET, DMT and etryptamine (Justice Laws; Canada Gazette).
Health Canada’s Canadian Drug and Substance Watch uses 5-MeO-DMT as its example of a “new psychoactive substance”, which it defines as a drug that has recently appeared on the illegal drug market, is “not currently controlled under the Controlled Drugs and Substances Act” and whose sale “is regulated under the Food and Drugs Act” (Health Infobase). That page was last modified on 19 March 2026, before the new regulations took effect. Not being in the CDSA does not mean anything goes: the Food and Drugs Act still governs the sale of drugs. We did not find a Health Canada decision on its status after 1 October 2026, so check the current schedules before relying on this.
Did British Columbia’s pilot decriminalize DMT?
No. The British Columbia exemption, a subsection 56(1) class exemption that took effect on 31 January 2023, covered adults possessing a cumulative amount of up to 2.5 grams of opioids, cocaine, methamphetamine or MDMA for personal use (Health Canada backgrounder). From 7 May 2024 a narrower replacement applied only in private residences, designated health care clinics, places where unhoused people were lawfully sheltering, and overdose prevention and drug checking sites. Its annex lists the covered substances by CDSA schedule and item, and DMT (Schedule III, item 7) is not among them (Health Canada exemption).
Health Canada’s page for that exemption now carries the notice “This exemption has expired” (Health Canada exemption). The Province of British Columbia says the exemption expired on 31 January 2026 and will not be renewed (Government of British Columbia). Our British Columbia guide covers the pilot’s history. Evidence: established.
DMT and Canadian law at a glance
| Question | What the official text says | Source |
|---|---|---|
| Is DMT scheduled? | Yes. Schedule III, item 7, “and any salt thereof”. | CDSA |
| Does the schedule exempt plants? | No exception in the DMT entry. Section 2(2) covers substances that contain a controlled substance and natural forms. | CDSA |
| Is DMT a restricted drug? | Yes. Item 4 of Part 1 of Schedule 4. | Controlled Substances Regulations |
| Harmaline and harmalol? | Schedule III, items 9 and 10; restricted drugs, items 6 and 7. | CDSA; Controlled Substances Regulations |
| 5-MeO-DMT? | Not named in the schedules we read. Health Canada called it not CDSA-controlled, with sale regulated under the Food and Drugs Act. | CDSA; Health Infobase (March 2026) |
| Religious ayahuasca use? | Only under a section 56 exemption held by the group; at least one application was under review in 2024. | CDSA; Information Commissioner |
| BC pilot? | Never covered DMT; expired 31 January 2026. | Health Canada; Province of BC |
What is still unsettled?
- Religious exemptions. Health Canada does not publish a list that we could find, so we cannot say which groups hold exemptions, for how long, or on what terms.
- 5-MeO-DMT after 1 October 2026. Health Canada’s most recent statement we found predates the new regulations.
- The new regulations in practice. Section 6(1)(g) lets an individual possess a restricted drug obtained for their own use from a practitioner named in a letter of authorization. We found no Health Canada guidance on how that works for DMT.
- Case law. We did not review court decisions on plant materials or ayahuasca. A lawyer can advise on those.
- Research results. The one DMT trial in Health Canada’s database had no posted results when we checked.
For the wider picture on psychedelics and Canadian law, see are magic mushrooms legal in Canada, our law tracker and, for the basics, what are magic mushrooms.
Common questions
Is DMT legal in Canada?
No. DMT is item 7 of Schedule III of the Controlled Drugs and Substances Act, so possession, trafficking, import, export and production are offences unless the regulations or a section 56 exemption authorize the activity. The Controlled Substances Regulations, in force since 1 October 2026, list it as a restricted drug.
What is the maximum penalty for DMT possession in Canada?
For a Schedule III substance, section 4(6) sets up to 3 years in prison on indictment. On summary conviction it is a fine up to $1,000 or up to 6 months, or both, for a first offence, and a fine up to $2,000 or up to 1 year, or both, for a later one. Trafficking, import, export and production carry up to 10 years on indictment.
Is ayahuasca legal in Canada?
Not generally. The Act covers any substance that contains a controlled substance, and DMT’s schedule entry has no plant exception. Health Canada has treated religious ayahuasca use as needing a section 56 exemption, and such an exemption usually covers only the group named in it.
Is 5-MeO-DMT illegal in Canada?
It is not named in the Act’s schedules or in Schedule 4 of the new regulations as we read them. Health Canada’s Drug and Substance Watch, last modified in March 2026, called it not controlled under the CDSA, with its sale regulated under the Food and Drugs Act. Check the current schedules, as this may change.
Did British Columbia decriminalize DMT?
No. The 2023 pilot covered opioids, cocaine, methamphetamine and MDMA only, and DMT is not in its annex of covered substances. The province says the exemption expired on 31 January 2026 and will not be renewed.
Is there any DMT research in Canada?
Health Canada’s Clinical Trials Database lists one product naming DMT, in a phase 2, randomized, placebo-controlled trial of an investigational DMT product in adults with treatment-resistant depression, with a no-objection letter dated 7 November 2024 and an ongoing status in October 2026. Its ClinicalTrials.gov record lists sites in Surrey and Kingston. No results were posted.
If someone needs urgent help after taking DMT, will calling 911 get them charged?
Section 4.1 of the CDSA says a person who seeks emergency help for a medical emergency caused by a psychoactive substance, or who is at the scene when help arrives, is not to be charged or convicted of simple possession under section 4(1) on evidence found because of that call. It covers that offence only. In an emergency, call 911.
Shroomverse sells mushroom products. This article is general information about Canadian drug law. It is not medical, legal or purchasing advice, it does not recommend any product, and it does not encourage anyone to use drugs.
SOURCES
- Controlled Drugs and Substances Act, S.C. 1996, c. 19 (current to 2026-09-30, last amended 2026-07-18), Justice Laws Website, Department of Justice Canada. Accessed . Full text read; section 56(1) re-read 24 October 2026. Supports Schedule III items 7 (DMT), 9 (harmaline), 10 (harmalol) and 17 (mescaline, “but not peyote”), the absence of any 5-MeO-DMT entry, sections 2(1) and 2(2), 4 to 7.1 and their maximum penalties, 4.1, Part I.1 and 56(1); also that the not-in-force amendments (SOR/2025-243) do not touch these items.
- Controlled Substances Regulations, SOR/2025-242, Canada Gazette, Part II, 17 December 2025. Accessed . Full text read. Supports coming into force on 1 October 2026 (section 239), the consolidation including Part J of the Food and Drug Regulations, the definitions of restricted drug and letter of authorization, section 6(1), and DMT, harmaline and harmalol at items 4, 6 and 7 of Part 1 of Schedule 4.
- Exemptions from provisions of the Controlled Drugs and Substances Act (page modified 2026-04-07), Health Canada. Accessed . Supports what an exemption is, case-by-case review, terms and conditions, and revocation for non-compliance.
- Health Canada (Re), 2024 OIC 10 (date modified 2024-05-17), Office of the Information Commissioner of Canada. Accessed . Full report read. Supports the existence of a religious exemption application to serve ayahuasca under section 56, under review at the time, which Health Canada said could set a precedent.
- Notice to stakeholders: Requests to the Special Access Program (SAP) involving psychedelic-assisted psychotherapy, Health Canada. Accessed . Supports SAP access to restricted drugs from January 2022, case-by-case review and that an authorization is not an endorsement. The notice names psilocybin and MDMA, not DMT.
- Clinical Trials Database: protocol VLS-01-203 (protocol ID 73344), Health Canada, via its Clinical Trials Database API. Accessed . API record read, plus the drug-product list naming ATAI Therapeutics and dimethyltryptamine (VLS-01-BU). Supports the trial design, condition, no-objection date 2024-11-07, start date 2025-06-04 and ongoing status.
- ClinicalTrials.gov API v2 search: dimethyltryptamine, U.S. National Library of Medicine. Accessed . Search run 20 October 2026: 61 records, none listing a Canadian site. The search does not return NCT06524830 (VLS-01), checked the same day.
- ClinicalTrials.gov record NCT06524830: VLS-01 buccal film vs placebo in treatment-resistant depression (ELUMINA), U.S. National Library of Medicine (record read via the ClinicalTrials.gov API). Accessed . Record read 20 October 2026 during the editorial review. Status recruiting; interventions named VLS-01-203 BU and placebo; locations include Surrey and Kingston, Canada.
- Understanding the data: Canadian Drug and Substance Watch (modified 2026-03-19), Health Canada, Health Infobase. Accessed . Supports the definition of new psychoactive substances and 5-MeO-DMT as the example, not controlled under the CDSA and with sale regulated under the Food and Drugs Act.
- Subsection 56(1) class exemption to possess small amounts of certain illegal substances in British Columbia: health care clinics, shelters and private residences, Health Canada. Accessed . Supports the expiry notice, the 7 May 2024 effective date, the places covered and the annex of covered substances, which does not include DMT.
- Personal possession of small amounts of certain illegal drugs in British Columbia (backgrounder, May 2024), Health Canada. Accessed . Supports the 31 January 2023 start and the original list: opioids, cocaine, methamphetamine and MDMA, up to 2.5 grams cumulative, adults 18 and older.
- Decriminalizing people who use drugs in B.C. (last updated 29 May 2026), Province of British Columbia. Accessed . Supports the expiry on 31 January 2026 and that it will not be renewed.
- Ontario Poison Centre, Ontario Poison Centre. Accessed . Home page read. Supports the number 1 800 268 9017 and availability 24 hours a day, every day of the year.
- 9-8-8 Suicide Crisis Helpline, 988.ca. Accessed . Home page read. Supports call or text 9-8-8.
CHANGES
- : Published. Statutory text checked against the CDSA consolidation current to 30 September 2026 and the Controlled Substances Regulations in force since 1 October 2026.
- : Editorial review: corrected the ClinicalTrials.gov comparison (the VLS-01 trial lists two Canadian sites but is missed by a keyword search) and added its record as a source; added evidence labels; split long paragraphs; named paragraph 6(1)(g); added links to related DMT guides.
- : Added source links beside figures and legal statements.
- : Narrowed “an exemption covers only its holder”: section 56(1) lets the Minister exempt a person, a class of persons or a substance, so an exemption usually covers only the person or group named in it. Checked against the CDSA text on 24 October 2026.



